Which treatment should we choose for tubo-ovarian abscesses? Results of an 8-year clinical training in a tertiary center
, 2, 3, 1, 1, 1, 4, 5
Abstract
Objectives: Tubo-ovarian abscess (TOA) is inflammation of the pelvic organs, mainly originating from the lower genital tract and intestinal tract. Treatment options include antibiotic therapy, surgical drainage, and radiologically guided (interventional) drainage. In our study, we aimed to evaluate the treatment method to be chosen and thus to manage patients with tuba ovarian abscesses (TOAs) most accurately.
Material and methods: This is a retrospective cohort study, and patients who applied to a tertiary center diagnosed with tuba ovarian abscess (TOA) were included. TOA size (cm), pre-treatment C-reactive protein (CRP) value, pre-treatment white blood cell (WBC) value, previous operation type, postoperative complication, and antibiotics used were screened.
Results: 305 patients were included in the study, and medical treatment was applied to 140 patients, organ-sparing surgical drainage to 50 patients, and surgical treatment to 115 patients. TOA dimensions measured at the time of diagnosis were significantly lower in patients for whom only medical treatment was sufficient. Pre-treatment CRP levels, WBC levels, and length of stay were significantly lower in patients for whom only medical treatment was sufficient. There was no significant difference between the pre-and post-procedure CRP difference, antibiotics, and hospitalization time.
Conclusions: Preferring minimally invasive treatment in cases requiring invasive treatment reduces the frequency of complications. Treatment of tuba ovarian abscesses (TOA) with minimally invasive methods will be more beneficial in terms of patient morbidity.
Keywords: minimally invasive treatmentsurgical drainagetubo-ovarian abscess
References
- Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol. 2009; 23(5): 667–678.
- Zeger W, Holt K. Gynecologic infections. Emerg Med Clin North Am. 2003; 21(3): 631–648.
- Krivak TC, Cooksey C, Propst AM. Tubo-ovarian abscess: diagnosis, medical and surgical management. Compr Ther. 2004; 30(2): 93–100.
- Wong TT, Lau HC, Tan TC. Retrospective study on the efficacy and prognostic factors of conservative versus drainage of tubo-ovarian abscesses. Arch Gynecol Obstet. 2020; 302(3): 679–683.
- Jalloul RJ, Patel RD. Clinical predictors of failed medical treatment in patients with tubo-ovarian abscess. J Minim Invasive Gynecol. 2021; 28(11): S60.
- Chan GM, Fong YF, Ng KL. Tubo-ovarian abscesses: epidemiology and predictors for failed response to medical management in an Asian population. Infect Dis Obstet Gynecol. 2019; 2019: 4161394.
- Goharkhay N, Verma U, Maggiorotto F. Comparison of CT- or ultrasound-guided drainage with concomitant intravenous antibiotics vs. intravenous antibiotics alone in the management of tubo-ovarian abscesses. Ultrasound Obstet Gynecol. 2007; 29(1): 65–69.
- Taira T, Broussard N, Bugg C, et al. Pelvic inflammatory disease: diagnosis and treatment in the emergency department. Emerg Med Pract. 2016; 18(12): 1–24.
- Jackson SL, Soper DE. Pelvic inflammatory disease in the postmenopausal woman. Infect Dis Obstet Gynecol. 1999; 7(5): 248–252, doi: 10.1002/(SICI)1098-0997(1999)7:5<248::AID-IDOG8>3.0.CO;2-V.
- Mirhashemi R, Schoell WM, Estape R, et al. Trends in the management of pelvic abscesses. J Am Coll Surg. 1999; 188(5): 567–572.
- Jalloul RJ, Thomas M, Ward C, et al. Clinical predictors of failed medical treatment in patients with tubo-ovarian abscess: external validation of a recently published risk score. J Minim Invasive Gynecol. 2022; 29(5): 649–655.
- Akselim B, Karaşin SS, Demirci A, et al. Can antibiotic treatment failure in tubo-ovarian abscess be predictable? Eur J Obstet Gynecol Reprod Biol. 2021; 258: 253–257.
- Goje O, Markwei M, Kollikonda S, et al. Outcomes of minimally invasive management of tubo-ovarian abscess: a systematic review. J Minim Invasive Gynecol. 2021; 28(3): 556–564.
- Zhu S, Ballard E, Khalil A, et al. Impact of early surgical management on tubo-ovarian abscesses. J Obstet Gynaecol. 2021; 41(7): 1097–1101.
- Chu L, Ma H, Liang J, et al. Effectiveness and adverse events of early laparoscopic therapy versus conservative treatment for tubo-ovarian or pelvic abscess: a single-center retrospective cohort study. Gynecol Obstet Invest. 2019; 84(4): 334–342.
- Sezgin B, Akin M, Kasap B. Outcomes of surgical practice on tubo-ovarian abscess in an academic hospital. Eur Res J. 2021; 7(1): 80–87.
- Fox CR, Paolillo SV, Downing KT. Predicting the need for a surgical intervention in the management of a tubo-ovarian abscess. J Minim Invasive Gynecol. 2021; 28(11): S131–S132.
